Both CD4+ and CD8+ T cells are capable of IFN-γ production; however the distribution of CD4+ and CD8+ T-cell responses against MAGE-A family antigens or p53 seems to vary with type of malignancy, type of antigen, and the level of antigen expression on tumor cells [27–29]. This evidence concerns the gene IFNG and neoplasm.